Horwith et al., 1976 - Google Patents
Hereditary bone dysplasia with hyperphosphatasaemia: response to synthetic human calcitoninHorwith et al., 1976
- Document ID
- 15812246923761050677
- Author
- Horwith M
- Nunez E
- Krook L
- Viteri F
- Torun B
- Mena E
- Suh S
- Eisenberg E
- MacIntyre I
- Whalen J
- Publication year
- Publication venue
- Clinical Endocrinology
External Links
Snippet
Four cases of familial bone dysplasia with hyperphosphatasaemia were treated with synthetic human calcitonin. Prior to therapy, all four cases were characterized by marked bone deformity, pain, tenderness and elevated levels of serum alkaline phosphatase and …
- 229940045644 Human calcitonin 0 title abstract description 13
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/50—Clinical applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McCUNE et al. | Osteodystrophia fibrosa: report of a case in which the condition was combined with precocious puberty, pathologic pigmentation of the skin and hyperthyroidism, with a review of the literature | |
| Albright et al. | Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females: report of five cases | |
| Aitken et al. | Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy | |
| BERNSTEIN et al. | Use of sodium fluoride in the treatment of osteoporosis | |
| BRUNZELL et al. | Congenital generalized lipodystrophy accompanied by cystic angiomatosis | |
| Bonnick et al. | Bone densitometry for technologists | |
| Daniels et al. | Tumorous phosphaturic osteomalacia: report of a case associated with multiple hemangiomas of bone | |
| Furst et al. | Polyostotic fibrous dysplasia: review of the literature with two additional cases | |
| Horwith et al. | Hereditary bone dysplasia with hyperphosphatasaemia: response to synthetic human calcitonin | |
| Whyte et al. | Mixed-sclerosing-bone-dystrophy: report of a case and review of the literature | |
| Adams et al. | Paravertebral and peripheral ligamentous ossification: an unusual association of hypoparathyroidism | |
| Saunders et al. | The radiographic appearance of canine congenital hypothyroidism: skeletal changes with delayed treatment | |
| Lucas et al. | Osteoporosis: The role of the orthopaedist | |
| Cassinelli et al. | Familial idiopathic hyperphosphatasia (FIH): response to long-term treatment with pamidronate (APD) | |
| Blanco et al. | Familial idiopathic hyperphosphatasia: a study of two young siblings treated with porcine calcitonin | |
| Kesson et al. | Generalized osteoporosis in old age | |
| Dent et al. | HEREDITARY PSEUDO-VITAMIN D DEFICIENCY RICKETS:(" Hereditare Pseudo-mangelrachitis") | |
| Allen et al. | Hypo-hyperparathyroidism | |
| Kaufman et al. | Bone and tissue changes following prostaglandin therapy in neonates | |
| Costa et al. | Skeletal dysplasias with gracile bones: Three new cases, including two offspring of a mother with a dwarfing condition | |
| Allen | Primary osteoporosis: methods to combat bone loss that accompanies aging | |
| Rucker et al. | A rare familial systemic affection of the skeleton: Fairbank's disease | |
| JP2001503728A (en) | Estrogens and parathyroid hormone for the treatment of osteoporosis | |
| JPH0121A (en) | Bone anti-porosis agent | |
| Vines | Polyostotic fibrous dysplasia |